UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method

Molecules (Basel, Switzerland), 2020-10, Vol.25 (20), p.4781

2020

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

Pharmaceutics, 2022-03, Vol.14 (3), p.572

2022

Volltextzugriff (PDF)

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models

EMBO molecular medicine, 2021-04, Vol.13 (4), p.e13076-n/a

2021

Volltextzugriff (PDF)

BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus

Scientific reports, 2019-07, Vol.9 (1), p.10888-13, Article 10888

2019

Volltextzugriff (PDF)

Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties

Pharmaceutical research, 2019-10, Vol.36 (10), p.138-12, Article 138

2019

Volltextzugriff (PDF)

Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson's Disease via a Vitamin D Receptor-Dependent Pathway

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8538

2020

Volltextzugriff (PDF)

Investigation of the factors responsible for the low oral bioavailability of alizarin using a sensitive LC‐MS/MS method: In vitro, in situ, and in vivo evaluations

Drug development research, 2023-05, Vol.84 (3), p.579-591

2023

Volltextzugriff (PDF)

Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents

Molecules (Basel, Switzerland), 2021-01, Vol.26 (2), p.425

2021

Volltextzugriff (PDF)

Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: Potential of its pharmacokinetic interactions in vivo

Biomedicine & pharmacotherapy, 2022-09, Vol.153, p.113514-113514, Article 113514

2022

Volltextzugriff (PDF)

Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and its Pharmacokinetic Application

Molecules (Basel, Switzerland), 2020-03, Vol.25 (6), p.1369

2020

Volltextzugriff (PDF)

Investigation of N -Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen

Pharmaceutics, 2023-05, Vol.15 (5), p.1471

2023

Volltextzugriff (PDF)

Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D 3 : Effects on in vivo oral absorption and disposition of buspirone in rats

Drug development research, 2019-05, Vol.80 (3), p.333-342

2019

Volltextzugriff (PDF)

Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson’s Disease

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8618

2022

Volltextzugriff (PDF)

Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties

Molecules (Basel, Switzerland), 2018-10, Vol.23 (10), p.2608

2018

Volltextzugriff (PDF)

Rhododendrin-Induced RNF146 Expression via Estrogen Receptor β Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress

International journal of molecular sciences, 2019-04, Vol.20 (7), p.1772

2019

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation

Pharmaceutics, 2024-02, Vol.16 (2), p.280

2024

Volltextzugriff (PDF)

Synthesis and anti‐diabetic activity of novel biphenylsulfonamides as glucagon receptor antagonists

Chemical biology & drug design, 2021-11, Vol.98 (5), p.733-750

2021

Volltextzugriff (PDF)

Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo

Redox biology, 2023-08, Vol.64, p.102783-102783, Article 102783

2023

Volltextzugriff (PDF)

Vitamin D Receptor Activation Down-regulates the Small Heterodimer Partner and Increases CYP7A1 to Lower Cholesterol

Gastroenterology (New York, N.Y. 1943), 2014-04, Vol.146 (4), p.1048-1059.e7

2014

Volltextzugriff (PDF)

TLR7-dependent eosinophil degranulation links psoriatic skin inflammation to small intestinal inflammatory changes in mice

Experimental & molecular medicine, 2024-05, Vol.56 (5), p.1164-1177

2024

Volltextzugriff (PDF)

Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution

Pharmaceutics, 2022-09, Vol.14 (9), p.1875

2022

Volltextzugriff (PDF)

The Role of Processed Aloe vera Gel in Intestinal Tight Junction: An In Vivo and In Vitro Study

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6515

2021

Volltextzugriff (PDF)

Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects

Pharmaceutics, 2021-01, Vol.13 (2), p.175

2021

Volltextzugriff (PDF)

Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson's Disease

International journal of molecular sciences, 2019-11, Vol.20 (21), p.5481

2019

Volltextzugriff (PDF)

Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats

Drug development research, 2019-05, Vol.80 (3), p.333-342

2019

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(141)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models

BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus

Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties

Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson's Disease via a Vitamin D Receptor-Dependent Pathway

Investigation of the factors responsible for the low oral bioavailability of alizarin using a sensitive LC‐MS/MS method: In vitro, in situ, and in vivo evaluations

Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents

Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: Potential of its pharmacokinetic interactions in vivo

Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and its Pharmacokinetic Application

Investigation of N -Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen

Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D 3 : Effects on in vivo oral absorption and disposition of buspirone in rats

Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson’s Disease

Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties

Rhododendrin-Induced RNF146 Expression via Estrogen Receptor β Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation

Synthesis and anti‐diabetic activity of novel biphenylsulfonamides as glucagon receptor antagonists

Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo

Vitamin D Receptor Activation Down-regulates the Small Heterodimer Partner and Increases CYP7A1 to Lower Cholesterol

TLR7-dependent eosinophil degranulation links psoriatic skin inflammation to small intestinal inflammatory changes in mice

Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution

The Role of Processed Aloe vera Gel in Intestinal Tight Junction: An In Vivo and In Vitro Study

Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects

Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson's Disease

Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats

Suchergebnisse filtern